Study on Bioequivalence of the Two Kinds of Isosorbide Mononotrate Tablets in Healthy Volunteers

赵建波,张丽慧,叶环,胡国新,代宗顺
DOI: https://doi.org/10.3969/j.issn.1007-0931.2007.11.006
2007-01-01
Abstract:Objective To study the relative bioavailability and bioequivalence of isosorbide mononotrate tablets in healthy volunteers.Methods A single oral dose(40mg of respective test and reference) was given to 18 healthy volunteer in a randomized crossover study with an interval of one week.Blood samplings were conducted consequently within 24 hours;the concentrations of isosorbide mononotrate in plasma were determined by high-performance liquid chromatography(HPLC). The relative bioavailability was calculated and bioequivalence was evaluated by DAS program.Analysis of variance and two one sides t test were used to test AUC(0-24),AUC(0-∞),and Cmax;rank test was used to test Tmax.Results After a single oral dose of test and reference preparations,Cmax of isosorbide mononotrate in plasma was 424.28±43.09μg·L-1 and 442.48±57.78μg·L-1, respectively;Tmax was 1.11±0.21h and 1.06±0.24h respectively;AUC(0-24) was 2855.09±276.27μg·h·L-1 and 3028.28±296.00μg·h·L-1;respectively;AUC(0-inf) was(3046.40±314.61) μg·h·L-1 and(3312.46±382.60) μg·h·L-1 respectively.The 90% confidence interval of AUC(0-24),AUC(0-∞) and Cmax was 90.3%~98.5%,87.2%~97.1% and 92.6%~99.9% respectively.Conclusions The relative bioavailability of test and reference preparations was(94.79±10.14)%,the two preparations are bioequivalent.
What problem does this paper attempt to address?